ReviewDiseases (Basel, Switzerland)2025

Efficacy and Safety of Adding Ribavirin to Sofosbuvir-Based Direct-Acting Antivirals (DAAs) in Re-Treating Non-Genotype 1 Hepatitis C-A Systematic Review and Meta-Analysis.

Shahd Hamran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.